Donate Help Contact The AHA Sign In Home
American Heart Association
Stroke
Search: search_blue_button Advanced Search
Stroke. 2006;37:556-561
Published online before print January 5, 2006, doi: 10.1161/01.STR.0000196942.84707.71
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
37/2/556    most recent
01.STR.0000196942.84707.71v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trouillas, P.
Right arrow Articles by von Kummer, R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trouillas, P.
Right arrow Articles by von Kummer, R.
Related Collections
Right arrow Fibrinogen/fibrin
Right arrow Acute Cerebral Infarction
Right arrow Computerized tomography and Magnetic Resonance Imaging
Right arrow Anticoagulants
Right arrow Antiplatelets
Right arrow Thrombolysis
Right arrow Coagulation and fibronolysis

(Stroke. 2006;37:556.)
© 2006 American Heart Association, Inc.


Comments, Opinions, and Reviews

Classification and Pathogenesis of Cerebral Hemorrhages After Thrombolysis in Ischemic Stroke

Paul Trouillas, MD Rüdiger von Kummer, MD

From the Cerebrovascular Unit, Hôpital Neurologique, Lyon, France (P.T.) and the Department of Neuroradiology, University Hospital, Dresden, Germany (R.vK).

Correspondence to Pr Paul Trouillas, Cerebrovascular Unit, Hôpital Neurologique, 59 Blvd Pinel, 69003 Lyon, France. E-mail paul.trouillas{at}chu-lyon.fr

Background and Purpose— Brain hemorrhage after ischemic stroke is a serious complication of treatment; however, its pathology is poorly understood. A classification based on brain imaging may help to better understand and avoid causal factors.

Methods— Review of the results of controlled randomized trials and the available literature.

Results— Hemorrhagic infarctions have no impact on clinical outcome and are probably not associated with the thrombolytic itself and the type of reperfusion strategy. They are associated with the extent of ischemic damage and most probably to an ischemic vasculopathy. Parenchymal hematomas are often clinically relevant. Their incidence is affected by the thrombolytic itself, the type, and probably the time point of reperfusion strategy. The loss of hemostatic control seems important in their pathogenesis. Extraischemic hematomas (remote from the infarct), unique or multiple, suggest pre-existing brain pathology, especially cerebral amyloid angiopathy.

Conclusions— The radiological description of 3 different types of brain hemorrhage is useful to better understand the specific pathology and the impact on clinical outcome. It may help to avoid clinically relevant brain hemorrhages.


Key Words: cerebral infarction • hemostasis • heparin • intracranial hemorrhage • thrombolysis




This article has been cited by other articles:


Home page
NeurologyHome page
M. W. Parsons, F. Miteff, G. A. Bateman, N. Spratt, A. Loiselle, J. Attia, and C. R. Levi
Acute ischemic stroke: Imaging-guided tenecteplase treatment in an extended time window
Neurology, March 10, 2009; 72(10): 915 - 921.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
L Derex and N Nighoghossian
Intracerebral haemorrhage after thrombolysis for acute ischaemic stroke: an update
J. Neurol. Neurosurg. Psychiatry, October 1, 2008; 79(10): 1093 - 1099.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Paciaroni, G. Agnelli, F. Corea, W. Ageno, A. Alberti, A. Lanari, V. Caso, S. Micheli, L. Bertolani, M. Venti, et al.
Early Hemorrhagic Transformation of Brain Infarction: Rate, Predictive Factors, and Influence on Clinical Outcome: Results of a Prospective Multicenter Study
Stroke, August 1, 2008; 39(8): 2249 - 2256.
[Abstract] [Full Text] [PDF]


Home page
Postgrad. Med. J.Home page
B R Thanvi, S Treadwell, and T Robinson
Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors
Postgrad. Med. J., July 1, 2008; 84(993): 361 - 367.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
W. S. Smith, G. Sung, J. Saver, R. Budzik, G. Duckwiler, D. S. Liebeskind, H. L. Lutsep, M. M. Rymer, R. T. Higashida, S. Starkman, et al.
Mechanical Thrombectomy for Acute Ischemic Stroke: Final Results of the Multi MERCI Trial
Stroke, April 1, 2008; 39(4): 1205 - 1212.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
K. Lin, K.S. Kazmi, M. Law, J. Babb, N. Peccerelli, and B.K. Pramanik
Measuring Elevated Microvascular Permeability and Predicting Hemorrhagic Transformation in Acute Ischemic Stroke Using First-Pass Dynamic Perfusion CT Imaging
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1292 - 1298.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Neuroradiol.Home page
N.A. Vora, R. Gupta, A.J. Thomas, M.B. Horowitz, A.H. Tayal, M.D. Hammer, K. Uchino, L.R. Wechsler, and T.G. Jovin
Factors Predicting Hemorrhagic Complications after Multimodal Reperfusion Therapy for Acute Ischemic Stroke
AJNR Am. J. Neuroradiol., August 1, 2007; 28(7): 1391 - 1394.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. G. Lansberg, V. N. Thijs, R. Bammer, S. Kemp, C. A.C. Wijman, M. P. Marks, G. W. Albers, and on behalf of the DEFUSE Investigators
Risk Factors of Symptomatic Intracerebral Hemorrhage After tPA Therapy for Acute Stroke
Stroke, August 1, 2007; 38(8): 2275 - 2278.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
M. Castellanos, T. Sobrino, M. Millan, M. Garcia, J. Arenillas, F. Nombela, D. Brea, N. Perez de la Ossa, J. Serena, J. Vivancos, et al.
Serum Cellular Fibronectin and Matrix Metalloproteinase-9 as Screening Biomarkers for the Prediction of Parenchymal Hematoma After Thrombolytic Therapy in Acute Ischemic Stroke: A Multicenter Confirmatory Study
Stroke, June 1, 2007; 38(6): 1855 - 1859.
[Abstract] [Full Text] [PDF]


Home page
J. Neurol. Neurosurg. PsychiatryHome page
P. Trouillas
Lowering the bleeding risk in intra-arterial thrombolysis without losing efficiency by excluding adjunctive heparin?
J. Neurol. Neurosurg. Psychiatry, March 1, 2007; 78(3): 222 - 223.
[Full Text] [PDF]


Home page
StrokeHome page
G. Thomalla, J. Sobesky, M. Kohrmann, J. B. Fiebach, J. Fiehler, O. Zaro Weber, A. Kruetzelmann, T. Kucinski, M. Rosenkranz, J. Rother, et al.
Two Tales: Hemorrhagic Transformation but Not Parenchymal Hemorrhage After Thrombolysis Is Related to Severity and Duration of Ischemia: MRI Study of Acute Stroke Patients Treated With Intravenous Tissue Plasminogen Activator Within 6 Hours
Stroke, February 1, 2007; 38(2): 313 - 318.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Khatri, L. R. Wechsler, and J. P. Broderick
Intracranial Hemorrhage Associated With Revascularization Therapies
Stroke, February 1, 2007; 38(2): 431 - 440.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
I. Dzialowski, J. H. W. Pexman, P. A. Barber, A. M. Demchuk, A. M. Buchan, M. D. Hill, and on behalf of the CASES Investigators
Asymptomatic Hemorrhage After Thrombolysis May Not Be Benign: Prognosis by Hemorrhage Type in the Canadian Alteplase for Stroke Effectiveness Study Registry
Stroke, January 1, 2007; 38(1): 75 - 79.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
R. Gupta, H. Yonas, J. Gebel, S. Goldstein, M. Horowitz, S. Z. Grahovac, L. R. Wechsler, M. D. Hammer, K. Uchino, and T. G. Jovin
Reduced Pretreatment Ipsilateral Middle Cerebral Artery Cerebral Blood Flow Is Predictive of Symptomatic Hemorrhage Post-Intra-Arterial Thrombolysis in Patients With Middle Cerebral Artery Occlusion
Stroke, October 1, 2006; 37(10): 2526 - 2530.
[Abstract] [Full Text] [PDF]